Effects of LBM and PPIs on Pharmacokinetics and Safety of Regorafenib (BAY 73-4506) in Cancer Patients
Clinical trial NCT02439723 · WITHDRAWN
Trial details
- NCT number
- NCT02439723
- Sponsor
- AHS Cancer Control Alberta
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-01
- Primary completion
- 2017-06-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.